EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy

Martina Palomba, Donatella Vecchio, Giulia Allavena, Vito Capaccio, Claudia De Mei, Rita Scarpelli iD, Benedetto Grimaldi iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.3c01432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Martina Palomba und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The autophagy process appears as a promising target for anticancer interventions. Chloroquine (CQ) and its derivative hydroxychloroquine (HCQ) are the only FDA-approved autophagy flux inhibitors. Although diverse anticancer clinical trials are providing encouraging results, several limitations associated with the need of high dosage and long-term administration of these autophagy inhibitors are also emerging. We showed that the inhibition of REV-ERB, a nuclear receptor regulating circadian rhythm and metabolism, enhances CQ-mediated cancer cell death and identified a class of dual inhibitors of autophagy and REV-ERB displaying an in vitro anticancer activity against diverse tumor cells greatly higher than CQ. Herein, we describe our lead optimization strategy that led to the identification of compound 24 as a dual autophagy and REV-ERB inhibitor, showing improved potency in blocking autophagy, enhanced toxicity against cancer cells, optimal drug-like properties, and efficacy in a mouse xenograft model of melanoma as a single anticancer agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansAnimalsMiceChloroquineAutophagyCell DeathCell Line, Tumor

Substanzen

Antineoplastic AgentsChloroquine

Autor:innen und Institutionen

ORCID-Profile: Rita Scarpelli, Benedetto Grimaldi

Zitieren

APA

Palomba, M., Vecchio, D., Allavena, G., Capaccio, V., De Mei, C., Scarpelli, R., & Grimaldi, B. (2024). Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01432

Vancouver

Palomba M, Vecchio D, Allavena G, Capaccio V, De Mei C, Scarpelli R, et al. Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c01432

BibTeX
@article{Palomba2024,
  author = {Palomba, Martina and Vecchio, Donatella and Allavena, Giulia and Capaccio, Vito and De Mei, Claudia and Scarpelli, Rita and Grimaldi, Benedetto},
  title = {Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.3c01432}
}
Kostenlos starten →